![John Rothman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Rothman
Chief Tech/Sci/R&D Officer at
RIZE ONCOLOGY INC.
Net worth: 14 470 $ as of 30/04/2025
Profile
John M.
Rothman is Chief Scientific Officer at Rize Oncology, Inc. since 2025.
Former positions include Senior Director at Schering-Plough Canada, Inc., EVP-Clinical & Scientific Operations at Advaxis, Inc. from 2011 to 2013, Chief Scientific Officer at Racura Oncology Ltd., and Executive Vice President-Product Development at Tyme Technologies, Inc. from 2020 to 2022.
Education includes a doctorate from Tulane University School of Medicine.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
RIZE ONCOLOGY INC. 1.32% | 06/01/2025 | 1,000,000 ( 1.32% ) | 14 470 $ | 30/04/2025 |
John Rothman active positions
| Companies | Position | Start |
|---|---|---|
| RIZE ONCOLOGY INC. | Chief Tech/Sci/R&D Officer | 09/01/2025 |
Former positions of John Rothman
| Companies | Position | End |
|---|---|---|
| TYME TECHNOLOGIES, INC. | Corporate Officer/Principal | 01/02/2022 |
| RACURA ONCOLOGY LTD | Chief Tech/Sci/R&D Officer | 01/10/2019 |
| AYALA PHARMACEUTICALS, INC. | Chief Operating Officer | 09/12/2011 |
Schering-Plough Canada, Inc.
 Schering-Plough Canada, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical preparations | Director/Board Member | - |
Training of John Rothman
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
15
1st degree connections
6
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Tyme Technologies, Inc.
 Tyme Technologies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops cancer metabolism-based therapeutics | Health Technology |
Advaxis, Inc.
 Advaxis, Inc. Pharmaceuticals: MajorHealth Technology Develops immunotherapies for cancer and infectious diseases | Health Technology |
Schering-Plough Canada, Inc.
Schering-Plough Canada, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical preparations | Health Technology |
Tulane University School of Medicine
 Tulane University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Race Oncology Ltd.
 Race Oncology Ltd. Pharmaceuticals: MajorHealth Technology Manufactures drugs for cancer | Health Technology |
GeneTether Therapeutics, Inc.
 GeneTether Therapeutics, Inc. BiotechnologyHealth Technology Develops gene editing therapies and platform | Health Technology |
- Stock Market
- Insiders
- John Rothman
